Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02441140 · ClinicalTrials.gov registry record · NA
Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis
A NA study, sponsored by Dana-Farber Cancer Institute.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT02441140: Clinical Trial NA study, sponsored by Dana-Farber Cancer Institute.
NCT02441140 is a NA study that was terminated before completion, run by Dana-Farber Cancer Institute. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02441140, a NA study, was terminated before completion, sponsored by Dana-Farber Cancer Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This research study is studying a possible test which may help doctors diagnose women with ovarian cancer.
Interventions
- PROCEDURE Blood collection
- PROCEDURE Tissue collection
- PROCEDURE Culdocentesis
- PROCEDURE Vaginal Swab
- PROCEDURE Chromopertubation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-05 |
| Est. Completion | 2019-07 |
| Phase | NA |
Why NCT02441140 stopped before completion
NCT02441140 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 5 interventions - of which Blood collection is the first listed.
NCT02441140 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02441140 about?
NCT02441140 is a clinical study titled "Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis". This research study is studying a possible test which may help doctors diagnose women with ovarian cancer.
What is the current status of trial NCT02441140?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2015-05. Estimated completion is 2019-07.
What interventions are being tested in trial NCT02441140?
The interventions under investigation include: Blood collection (PROCEDURE), Tissue collection (PROCEDURE), Culdocentesis (PROCEDURE), Vaginal Swab (PROCEDURE), Chromopertubation (PROCEDURE).
Who is sponsoring clinical trial NCT02441140?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02441140's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia